JH

James Hendrix

AP Aventis Pharmaceuticals: 5 patents #36 of 454Top 8%
OL Oligomerix: 3 patents #3 of 13Top 25%
Overall (All Time): #603,450 of 4,157,543Top 15%
8
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
12331043 Benzofuran, benzothiophene, and indole analogs that inhibit the formation of tau oligomers and their method of use Eliot J. Davidowitz, James G. Moe, Allen B. Reitz, Haiyan Bian, Charles Gluchowski +3 more 2025-06-17
11472776 Quinazolinones that inhibit the formation of tau oligomers and their method of use Eliot J. Davidowitz, James G. Moe, Allen B. Reitz, Haiyan Bian, Charles Gluchowski +3 more 2022-10-18
11306075 Benzofuran, benzothiophene, and indole analogs that inhibit the formation of tau oligomers and their method of use Eliot J. Davidowitz, James G. Moe, Allen B. Reitz, Haiyan Bian, Charles Gluchowski +3 more 2022-04-19
7772252 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands Horst Hemmerle, Matthias Urmann, Gregory M. Shutske, Joseph T. Strupczewski, Kenneth J. Bordeau +10 more 2010-08-10
7550469 Heterocyclic amide derivatives and their use as dopamine D3 receptor ligands Joseph T. Strupczewski, Kenneth J. Bordeau, Matthias Urmann, Gregory M. Shutske, Horst Hemmerle +7 more 2009-06-23
7521445 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands Horst Hemmerle, Matthias Urmann, Gregory M. Shutske, Joseph T. Strupczewski, Kenneth J. Bordeau +10 more 2009-04-21
7253165 Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists Gregory M. Shutske, John G. Jurcak, Brian S. Freed, Nicholas J. Hrib, John D. Tomer, IV +1 more 2007-08-07
7186724 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands Horst Hemmerle, Matthias Urmann, Gregory M. Shutske, Jospeh T Strupczewski, Kenneth J. Bordeau +10 more 2007-03-06